SCHEMBL6963657

SCHEMBL6963657

O=C(COCCCc1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.61
RAB9A P51151 4/20 0.61
CASP3 P42574 1/20 0.61
SENP8 Q96LD8 1/20 0.61
SENP7 Q9BQF6 1/20 0.61
SENP6 Q9GZR1 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
LMNA P02545 1/20 0.53
DPP4 P27487 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
FFAR1 O14842 1/20 0.47
RECQL P46063 1/20 0.47
IDO1 P14902 1/20 0.47
HDAC3 O15379 1/20 0.47
MAPK1 P28482 1/20 0.47
ADRA1A P35348 1/20 0.47
HDAC4 P56524 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7376345 0.89 TDP1 (0.55) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL11617258 0.85 TDP1 (0.55) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL5639162 0.84 LMNA (0.58) NPC1RAB9ATDP1LMNASMN1; SMN2
SCHEMBL1742078 0.81 TSHR (0.49) NPC1RAB9ATDP1LMNASMN1; SMN2
SCHEMBL15099515 0.81 LMNA (0.54) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL22266213 0.81 LMNA (0.64) NPC1RAB9ATDP1LMNASMN1; SMN2
SCHEMBL10665429 0.81 ALDH1A1 (0.52) NPC1RAB9ATDP1LMNASMN1; SMN2
SCHEMBL7044825 0.81 GSK3B (0.52) NPC1RAB9ACASP3SENP8SENP7
SCHEMBL524255 0.79 CES2 (0.50) LMNAMAPK1
SCHEMBL10762940 0.79 TDP1 (0.49) NPC1RAB9ATDP1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
US-4038412-A ANTI-VIRAL AGENTS RICHARDSON-MERRELL INC. (US) 1977-07-26 US disclosed